GlassScriptPhysician profile
Arundhati Biswas
NPI 1326297565
$8,156.86
in general payments reported to CMS, 2019-2025
22 companies · $2,869 in 2025
The $2,869 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $620 · 2020: $57.37 · 2021: $769 · 2022: $407 · 2023: $1,964 · 2024: $1,471 · 2025: $2,869.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,547 · Food and Beverage: $1,736 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,547.37 |
| Food and Beverage | $1,736.44 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,843.43 | 2021-2025 | Intellis Adaptivestim, Stealthstation S8 Platform, Mazor X System |
| Si-Bone, INC. | $1,096.59 | 2022-2023 | |
| Cordis US Corp. | $1,047.27 | 2024 | Angioguard |
| Alafair Biosciences, INC. | $614.54 | 2023 | Versawrap |
| Globus Medical, INC. | $543.85 | 2020-2025 | Excelsius Gps, Bendini, Sable |
| Stryker Corporation | $519.98 | 2019 | |
| Penumbra, INC. | $469.89 | 2021 | |
| Microvention, INC. | $286.75 | 2019-2023 | Web Aneurysm Embolization System, Stent |
| Boston Scientific Corporation | $188.54 | 2020-2023 | |
| Nuvasive, INC. | $139.20 | 2022 | |
| Foundation Fusion Solutions, LLC | $81.04 | 2022-2024 | |
| Alphatec Spine, INC | $40.70 | 2024 | Other - Miscellaneous |
| Zimvie INC. | $38.37 | 2024 | |
| Inspire Medical Systems, INC. | $34.45 | 2024 | Inspire |
| 4web, INC. | $34.10 | 2024 | Spine Truss System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Augmedics INC. | $32.37 | 2024 | Xvision |
| Merz Pharmaceuticals, LLC | $30.43 | 2024 | Xeomin |
| Medtronic USA, INC. | $26.36 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $24.74 | 2024 | Andexxa |
| Orthofix Medical, INC. | $24.26 | 2023 | M6-C, Newbridge |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Integra Lifesciences Corporation | $20.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arundhati Biswas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.